A real estate and technology investor, Hilt Tatum IV leads iPoint Capital Partners as founder and president. Among Hilt Tatum IV’s tech investments is Medopad, which combines modern technology with artificial intelligence to improve healthcare outcomes.
In November 2017, Medopad won Accenture’s Healthcare Innovation Challenge semifinal held in London, UK. The win secured Medopad’s place as one of the nine health startups from around the world at the challenge’s final held at the Startup Health Festival in San Francisco, California, in January 2018.
The Healthcare Innovation Challenge recognizes health startups from around the world that are developing solutions for the biggest challenges to global healthcare including access, management, affordability, and information security. Winning at the semifinal level is no small feat.
Participants send their applications ahead of the deadline after which applications are reviewed and a shortlist is made. Shortlisted candidates are invited for pitching rounds in either Boston, London, or Singapore. They receive coaching on pitching from Accenture coaches after which they pitch to a panel of healthcare industry professionals and investors. It is this panel that ultimately decides the semifinal winners. In 2017, the judges included Sarah Ahmad, SVP at Highmark Health; Paul Von Autenried, CIO at Bristol-Myers Squibb; and Susan Lorraine-Bennett, director at MSD.
Hilt Tatum is CEO of Oxford Consulting Group - International business consulting